NCT05600283View on ClinicalTrials.gov

Patient Self-sampling of HPV to Screen for Cervical Cancer

NACompletedINTERVENTIONAL
Enrollment

225

Participants

Timeline

Start Date

November 16, 2022

Primary Completion Date

June 4, 2024

Study Completion Date

June 4, 2024

Conditions
Human Papilloma Virus
Interventions
DIAGNOSTIC_TEST

Swab kit (COBAS HPV 4800 Assay -Evalyn brush)

Patient self-sampling swab kit to collect a vaginal sample for HPV testing

DIAGNOSTIC_TEST

Clinician-collection of cervical sample for HPV testing

Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)

Trial Locations (1)

55905

Mayo Clinic Minnesota, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05600283 - Patient Self-sampling of HPV to Screen for Cervical Cancer | Biotech Hunter | Biotech Hunter